[Treatment of disseminated intravascular coagulation].
Takatoshi
T
Koyama
D000925:Anticoagulants / Q000008:administration & dosage*; D000991:Antithrombins / Q000008:administration & dosage; D001550:Benzamidines; D002809:Chondroitin Sulfates / Q000008:administration & dosage; D017985:Dalteparin / Q000008:administration & dosage; D003871:Dermatan Sulfate / Q000008:administration & dosage; D004211:Disseminated Intravascular Coagulation / Q000209:etiology / Q000628:therapy*; D016670:Gabexate / Q000008:administration & dosage; D006146:Guanidines / Q000008:administration & dosage; D006493:Heparin / Q000008:administration & dosage; D006497:Heparan Sulfate / Q000008:administration & dosage; D006801:Humans; D011480:Protease Inhibitors / Q000008:administration & dosage; D011486:Protein C / Q000008:administration & dosage; D011994:Recombinant Proteins / Q000008:administration & dosage; D018180:Thrombomodulin / Q000008:administration & dosage; D014212:Tretinoin / Q000008:administration & dosage
D000925:Anticoagulants; D000991:Antithrombins; D001550:Benzamidines; D002809:Chondroitin Sulfates; D017985:Dalteparin; D003871:Dermatan Sulfate; D016670:Gabexate; D006146:Guanidines; D006493:Heparin; D006497:Heparan Sulfate; D011480:Protease Inhibitors; D011486:Protein C; D011994:Recombinant Proteins; D018180:Thrombomodulin; D014212:Tretinoin; C035838:danaparoid; C032855:nafamostat